Effectiveness of a social cognition treatment (T-ScEmo) in patients with moderate to severe traumatic brain injury
- Conditions
- Traumatic brain injury in the subacute and chronic phase of recovery, with deficits in social cognitionNervous System Diseases
- Registration Number
- ISRCTN81350364
- Lead Sponsor
- Hersenstichting Nederland (Dutch Brain Foundation)
- Brief Summary
2017 results in https://pubmed.ncbi.nlm.nih.gov/28786854/ (added 27/11/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 61
1. Moderate to severe traumatic brain injury
2. Sub-acute or chronic stage of recovery
3. Referred on clinical grounds, that is, being identified as having changes in social functioning, with at least 1 deficit in social cognition tests and/or proxy ratings on the BAFQ-social monitoring and/or empathy scale>10
4. Orbitofrontal/medioprefrontal brain damage demonstrated with MRI
5. Presence of a proxy to fill in questionnaires
1. Neurodegenerative or psychiatric illness
2. Severe cognitive impairment that would preclude treatment (i.e. amnestic syndrome, global aphasia, neglect)
3. Very severe behavioral regulation deficits for which continuous external control was needed and/or physical aggressiveness
4. Severe depression
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of social cognition (pre- to postmeasurement) on the Awareness of Social Inferences Test (TASIT-short) at baseline, within 2 weeks of the last treatment session and at 3-5 monts follow up.
- Secondary Outcome Measures
Name Time Method